Patents by Inventor Gye Rim Baek

Gye Rim Baek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Acylated oxyntomodulin peptide analog
    Patent number: 11713344
    Abstract: A novel peptide analog of acylated oxyntomodulin and its uses are disclosed. A pharmaceutical composition containing the novel peptide analog is useful and effective for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptide analog and a composition containing the peptide analog are superior to those of wild-type oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition containing the peptide analog is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
    Type: Grant
    Filed: August 24, 2021
    Date of Patent: August 1, 2023
    Assignee: DONG-A ST CO., LTD.
    Inventors: Jae-Sung Yang, Kyung-Seok Lee, Yu-Na Chae, Gye-Rim Baek, Tae-Hyoung Kim, Ill-Hun Jung, Chae-Lim Ryu, Weon-Bin Im
  • ACYLATED OXYNTOMODULIN PEPTIDE ANALOG
    Publication number: 20220119473
    Abstract: A novel peptide analog of acylated oxyntomodulin and its uses are disclosed. A pharmaceutical composition containing the novel peptide analog is useful and effective for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptide analog and a composition containing the peptide analog are superior to those of wild-type oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition containing the peptide analog is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
    Type: Application
    Filed: August 24, 2021
    Publication date: April 21, 2022
    Applicant: DONG-A ST CO., LTD.
    Inventors: Jae-Sung YANG, Kyung-Seok LEE, Yu-Na CHAE, Gye-Rim BAEK, Tae-Hyoung KIM, Ill-Hun JUNG, Chae-Lim RYU, Weon-Bin IM
  • Acylated oxyntomodulin peptide analog
    Patent number: 11236142
    Abstract: The present invention relates to a novel peptide analog of acylated oxyntomodulin and a pharmaceutical composition comprising the same for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptides are superior to those of natural oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition comprising said peptides is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
    Type: Grant
    Filed: August 16, 2018
    Date of Patent: February 1, 2022
    Assignee: DONG-A ST CO., LTD.
    Inventors: Jae-Sung Yang, Kyung-Seok Lee, Yu-Na Chae, Gye-Rim Baek, Tae-Hyoung Kim, Ill-Hun Jung, Chae-Lim Ryu, Weon-Bin Im
  • ACYLATED OXYNTOMODULIN PEPTIDE ANALOG
    Publication number: 20200354425
    Abstract: The present invention relates to a novel peptide analog of acylated oxyntomodulin and a pharmaceutical composition comprising the same for preventing and treating obesity or overweightness, or diabetes accompanied by obesity and overweightness. The peptides are superior to those of natural oxyntomodulin in dual agonism on GLP-1 and glucagon receptors and longer in vivo half-life. A pharmaceutical composition comprising said peptides is effective in the treatment of metabolic diseases such as obesity and diabetes mellitus.
    Type: Application
    Filed: August 16, 2018
    Publication date: November 12, 2020
    Applicant: DONG-A ST CO., LTD.
    Inventors: Jae-Sung YANG, Kyung-Seok LEE, Yu-Na CHAE, Gye-Rim BAEK, Tae-Hyoung KIM, Ill-Hun JUNG, Chae-Lim RYU, Weon-Bin IM
  • Substituted piperidines having GPR119 agonistic activity
    Patent number: 10428055
    Abstract: The present invention relates to a substituted piperidines represented by following Chemical Formula 1, which have a GPR119 agonistic activity, a method for preparing the same, and a pharmaceutical composition including the same: wherein A, B, and X are defined therein.
    Type: Grant
    Filed: July 24, 2015
    Date of Patent: October 1, 2019
    Assignee: DONG-A ST CO., LTD.
    Inventors: Jae Sung Yang, Gye Rim Baek, Yoon Jung Kim, Chi Young Ahn, Jae Young Lee, Il Hoon Jung, Mi Kyung Kim, So Mi Kang, Hyo Ju Lee, Yu Na Chae, Ye Hwang Cheong, Tae Hyoung Kim, Eun Kyoung Yang, Moon Ho Son, Chang Yell Shin
  • COMPOUND HAVING GPR119 AGONISTIC ACTIVITY, METHOD FOR PREPARING THE SAME, AND PHARMAECUTICAL COMPOSITION INCLUDING THE SAME AS EFFECTIVE COMPONENT
    Publication number: 20190092763
    Abstract: The present invention relates to a novel compound having a GPR119 agonistic activity, a method for preparing the same, and a pharmaceutical composition including the same as an effective component. The present invention has an effective hypoglycemic action and an effect on pancreatic beta cells, and also improves lipid metabolism which is a chronic cardiovascular risk factor, thereby having a treatment and/or prevention effect of a metabolic disease such as diabetes.
    Type: Application
    Filed: July 24, 2015
    Publication date: March 28, 2019
    Applicant: DONG-A ST CO., LTD.
    Inventors: Jae Sung Yang, Gye Rim Baek, Yoon Jung Kim, Chi Young Ahn, Jae Young Lee, Il Hoon Jung, Mi Kyung Kim, So Mi Kang, Hyo Ju Lee, Yu Na Chae, Ye Hwang Cheong, Tae Hyoung Kim, Eun Kyoung Yang, Moon Ho Son, Chang Yell Shin